- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05235880
Effects of Virtual Reality Based Games in Rehabilitation of Parkinson's Disease
September 20, 2023 updated by: Muhammed KILINÇ, Hacettepe University
Effects of Virtual Reality Based Games on Upper Extremities, Trunk and Cognitive Functions in Parkinson's Disease
The purpose of this study is to investigate the effects of virtual reality based games on upper extremities, trunk and cognitive functions in patients with Parkinson's Disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey
- Hacettepe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with Parkinson's disease
- 50 years old and over
- Stage 1.5-3 according to the modified Hoehn-Yahr Staging Scale
- Mini mental test score of 24 and above
Exclusion Criteria:
- Additional neurological disease or symptom other than Parkinson's disease
- Orthopedic disorder that will prevent them from doing exercises
- Severe mental disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: study group
1 hour physiotherapy session for 3 times a week and 8 weeks in total.
|
In an hour physiotherapy session first 40 minutes of session includes conventional physiotherapy program tailored to patient's needs.
Last 20 minutes of session includes virtual reality based games aiming improvement on upper extremities, trunk and cognitive functions.
|
|
Active Comparator: control group
1 hour physiotherapy session for 3 times a week and 8 weeks in total.
|
In an hour physiotherapy session first 40 minutes of session includes conventional physiotherapy program tailored to patient's needs.
Last 20 minutes of session includes conventional physiotherapy approaches aiming improvement on upper extremities, trunk and cognitive functions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Upper extremities performance with 9 hole peg test
Time Frame: Change from Baseline at 8 weeks
|
The patient sits with a table in front of him/her and places 9 small wooden sticks on the surface with nine holes on them, takes them out again and lays them on his/her side.
He/she is asked to do it as quickly as possible and his/her time is saved
|
Change from Baseline at 8 weeks
|
|
Upper extremities performance with Minnesota Manual Dexterity Test
Time Frame: Change from Baseline at 8 weeks
|
It involves taking small disc-shaped objects, each of standard size, to different distances on the table in the shortest possible time and placing them in sequence, while the patient is in a sitting position with a table in front of him/her.
|
Change from Baseline at 8 weeks
|
|
Cognitive Status with Montreal Cognitive Assessment
Time Frame: Change from Baseline at 8 weeks
|
its validity and reliability in Turkish have been established.
The total score ranges from 0-30, and a higher score indicates a better cognitive status.
Below 21 points indicates cognitive impairment.
|
Change from Baseline at 8 weeks
|
|
Trunk Functions with Trunk Impairment Scale
Time Frame: Change from Baseline at 8 weeks
|
It is a valid and reliable scale for evaluating the motor disorders and balance of the trunk in Parkinson's patients.
The total score in the scale, which consists of 17 items in 3 sections, ranges from 0 to 23.
A higher score indicates better trunk function and balance.
|
Change from Baseline at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dynamic balance with functional reach test
Time Frame: Change from Baseline at 8 weeks
|
Functional reach test is frequently used to assess dynamic balance and fall risk.
While the patient is standing by the wall, he/she raises his/her arm to 90 degrees and tries to reach as far as he/she can without taking his/her feet off the ground.
Extending a longer distance indicates better balance and less risk of falling
|
Change from Baseline at 8 weeks
|
|
Balance and mobility with Timed Up and Go Test
Time Frame: Change from Baseline at 8 weeks
|
While the patient is in a sitting position, he/she is asked to stand up from the chair, walk 3 meters, turn around, come back and sit down, and the time is recorded.
Doing it in less time demonstrates better balance and mobility
|
Change from Baseline at 8 weeks
|
|
Quality of life with Parkinson's Disease Questionnaire
Time Frame: Change from Baseline at 8 weeks
|
The 39-item Parkinson's Disease Questionnaire was developed to evaluate the quality of life of Parkinson's patients and has Turkish validity and reliability.
Higher scores mean worse outcome.
|
Change from Baseline at 8 weeks
|
|
Disease severity and symptoms with Unified Parkinson Disease Rating Scale Part 2 and 3
Time Frame: Change from Baseline at 8 weeks
|
It is one of the most frequently used scales to evaluate the severity of the disease in Parkinson's patients.
It evaluates many problems such as motor and non-motor problems, treatment complications, problems in daily living activities and consists of 4 sections.
However, in our study, the 2nd and 3rd sections which evaluate motor problems and activities of daily living will be used.
Higher scores mean worse outcome.
|
Change from Baseline at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gül Yalçın Çakmaklı, Assoc. Prof., Hacettepe University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19.
- Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76. doi: 10.1136/jnnp.2007.131045.
- Abbruzzese G, Marchese R, Avanzino L, Pelosin E. Rehabilitation for Parkinson's disease: Current outlook and future challenges. Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S60-4. doi: 10.1016/j.parkreldis.2015.09.005. Epub 2015 Sep 3.
- Allen NE, Song J, Paul SS, Smith S, O'Duffy J, Schmidt M, Love R, Sherrington C, Canning CG. An interactive videogame for arm and hand exercise in people with Parkinson's disease: A randomized controlled trial. Parkinsonism Relat Disord. 2017 Aug;41:66-72. doi: 10.1016/j.parkreldis.2017.05.011. Epub 2017 May 15.
- Levin MF. Can virtual reality offer enriched environments for rehabilitation? Expert Rev Neurother. 2011 Feb;11(2):153-5. doi: 10.1586/ern.10.201. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2022
Primary Completion (Actual)
June 15, 2023
Study Completion (Actual)
June 15, 2023
Study Registration Dates
First Submitted
December 22, 2021
First Submitted That Met QC Criteria
February 2, 2022
First Posted (Actual)
February 11, 2022
Study Record Updates
Last Update Posted (Actual)
September 21, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA-21067
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Virtual reality based games
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainRecruitingStroke | Cognitive Impairment | Healthy Subjects | HemiparesisBelgium
-
TOPMEDNatural Sciences and Engineering Research Council, Canada; SEC Fonds Immobilier... and other collaboratorsCompleted
-
Indiana UniversityCompletedPhysical ActivityUnited States
-
Fondazione Don Carlo Gnocchi OnlusUniversity of BremenCompletedStroke | Multiple Sclerosis
-
University of MalagaNot yet recruiting
-
Istanbul University - Cerrahpasa (IUC)CompletedAdolescent Idiopathic ScoliosisTurkey
-
Universidad de MurciaCompletedStroke | Physical Therapy | Virtual RealitySpain
-
Marjean KulpBeta Sigma Kappa - College of Optometrists in Vision Development; VividVisionRecruiting
-
Riphah International UniversityRecruiting
-
Istanbul Medipol University HospitalRecruiting